PRESS RELEASE

NEW CONTRACTS ABROAD IN THE SECOND QUARTER

WORTH OVER EUR 5 MILLION

Riedl Phasys automation in China for over EUR 1.4 mln

New donor transfusion centre in Texas

Trento, 18 July 2023

GPI S.p.A. (GPI:IM), a company listed in the Tech Leader segment of Euronext Milan, announces that it signed new international contracts worth more than EUR 5 million in the second quarter of 2023.

Its flagship technology products are winning over international customers, from the HIS software for triage in Austria to the T1 monitor, the sensor for telemedicine at Umana Medical in China, to robots for pharmacy automation and transfusion software.

In particular, Riedl Phasys won new contracts in Germany, Switzerland and Hungary and expanded into China and Japan with pharmacy automation worth over EUR 2.8 million, more than half of which generated in Asian countries.

Gpi4Blood's product suite with its modular solutions, which meet the needs of the most demanding customers, increased sales by up-selling and gained new customers for a total of EUR 2.2 million. Mention should be made of the positive effect of synergies resulting from the acquisition of Tesi, which offers its own blood product in Spain, where Gpi has had a strong presence in the Blood Management sector for years, as well as of the construction of a new donor centre for a new customer in Texas for a value of just under EUR 1 million.

| GPI SPA | Via Ragazzi del '99, 13 - 38123 Trento | www.gpigroup.com

PRESS RELEASE

GPI GROUP

GPI is the partner of choice for software, technologies and services for healthcare, social services and the public administration. Founded more than 30 years ago in Trento, GPI has grown through significant investments in M&A (in Italy and abroad) and in R&D, carried out in partnership with leading Italian universities and research centres to transfer scientific, technological, functional and process knowledge into the e-health,e-welfare, and well-being sectors.

Also drawing on the solutions and know-how gained from the companies that have joined its ecosystem, the Group has masterfully translated the needs of the healthcare industry into cutting-edgehigh-tech solutions and new service models that optimise prevention, diagnosis and care processes, improving people's lives.

The offer combines specialised IT expertise with advisory and design capabilities enabling it to operate in a range of business areas: Software, Care, Automation, ICT and Payment services.

The Company reported consolidated revenues of €360.2 million in 2022, with over 7,100 employees at year end, and more than 3,000 customers in over 70 countries.

GPI was listed on Borsa Italiana in 2016 (AIM segment) and moved to the MTA (now EXM) market in 2018. In 2023 becomes part of Euronext Tech Leaders, the initiative of Borsa Italiana dedicated to high-growth and leading Tech Companies.

ISIN ordinary shares: IT0005221517

Press release available at www.gpigroup.com and www.1info.it

CONTACTS

Investor Relations

GPI | Fabrizio Redavid, Lorenzo Giollo | investor.relations@gpi.it | T: +390461381515 | Via Ragazzi del '99, 13 - 38123 Trento

Media Relations

GPI | Daniela Filbier, Enrico Orfano| media.relations@gpi.it | T: +390461381515 | Via Ragazzi del '99, 13 - 38123 Trento

Specialist

Banca Akros | Bruno Mestice | bruno.mestice@bancaakros.it | T. +3902434441 | Viale Eginardo, 29 - 20149 Milan

2

Attachments

  • Original Link
  • Original Document
  • Permalink

Disclaimer

GPI S.p.A. published this content on 18 July 2023 and is solely responsible for the information contained therein. Distributed by Public, unedited and unaltered, on 18 July 2023 10:10:18 UTC.